SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
DATE OF REPORT - AUGUST 26, 2002
(Date of earliest event reported)
ALKERMES, INC.
(Exact name of Registrant as specified in its charter)
PENNSYLVANIA 0-19267 23-2472830
(State of incorporation) (Commission file number) (IRS employer
identification number)
88 SIDNEY STREET, CAMBRIDGE, MASSACHUSETTS 02139
(Address of principal executive offices, zip code)
AREA CODE (617) 494-0171
(Telephone number)
ITEM 5. OTHER INFORMATION.
On August 26, 2002, Alkermes, Inc. (the "Company") reduced its
workforce by 122 employees, representing approximately 23% of the Company's
employees. This reduction in workforce will reduce the total number of Company
employees to 419 from 541 employees. The reduction is across all functions of
the Company. Affected employees were offered a severance package that included
severance pay, continuation of benefits and outplacement services. In connection
with the reduction in workforce, the Company plans to close its medical affairs
office located in Cambridge, England.
SIGNATURES
Pursuant to requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Dated: August 27, 2002 Alkermes, Inc.
By: /s/ James M. Frates
--------------------------------
James M. Frates
Vice President, Chief Financial
Officer, and Treasurer